• NEWS

Scores of coronavirus vaccines are in competition — how will scientists choose the best?

Developers and funders are laying the groundwork for efficacy trials, but only a handful of vaccines are likely to make the cut.
By
  1. Ewen Callaway
    View author publications

    You can also search for this author in PubMed  Google Scholar

Access through your institution
Buy or subscribe

Less than five months after the world first learnt about the new coronavirus causing fatal pneumonia in Wuhan, China, there are more than 90 vaccines for the virus at various stages of development, with more announced each week. At least six are already being tested for safety in people.

Access options

Access through your institution

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-020-01247-2

Subjects

Latest on:

Who is on RFK Jr’s new vaccine panel — and what will they do?

Who is on RFK Jr’s new vaccine panel — and what will they do?

News

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing